Johnson & Johnson (JNJ -0.6%) unit Janssen Biotech commits to upfront and prospective milestone payments to California-based Second Genome in connection with a collaborative venture aimed at finding new treatments for ulcerative colitis.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Benzinga.com (Feb 23, 2015)
at Nasdaq.com (Feb 19, 2015)
at Nasdaq.com (Feb 17, 2015)
at Nasdaq.com (Feb 10, 2015)
at Investor's Business Daily (Jan 20, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs